4
Changes in Ownership
Telix Pharmaceuticals Ltd Filed Acc 0001628280-26-022909
Group Chief Financial Officer acquired 1,111 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith Darren Charlton Group Chief Financial Officer | 2026-03-29 | Option exercise | +1,111 | 11,921 | D | ||
| Derivatives | |||||||
| Smith Darren Charlton Group Chief Financial Officer | 2026-03-29 | Option exercise · Share Rights | −1,111 | 0 | D | ||
Loading xslF345X06/wk-form4_1775085272.xml…